Literature DB >> 1989762

Gastric tonometry in healthy volunteers: effect of ranitidine on calculated intramural pH.

S O Heard1, C M Helsmoortel, J C Kent, A Shahnarian, M P Fink.   

Abstract

OBJECTIVE: To determine if intraluminal production of CO2 leads to underestimation of gastric intramural pH (pHi) by tonometry.
DESIGN: Nonrandomized controlled study. PATIENTS: Healthy volunteers.
INTERVENTIONS: NG tonometers were placed in healthy volunteers. Some of the volunteers (n = 11) were pretreated with ranitidine to prevent secretion of protons into the gastric lumen. Others (n = 13) were untreated (i.e., gastric acid secretion was uninhibited).
MEASUREMENTS AND MAIN RESULTS: Gastric pHi was calculated from the arterial (HCO3-) and the tonometrically determined intraluminal PCO2 using the Henderson-Hasselbalch equation. Intraluminal PCO2 was significantly higher in the control group (54 +/- 14 torr [7.2 +/- 1.9 kPa]) than in the ranitidine-treated group (42 +/- 4 torr [5.6 +/- 0.4 kPa], p = .02). Mean gastric luminal pH was 1.9 +/- 0.6 in the control group as compared with 6.7 +/- 0.7 in volunteers treated with ranitidine (p less than .01). Mean calculated gastric pHi was 7.30 +/- 0.11 in the untreated group and 7.39 +/- 0.03 in the ranitidine-treated group (p less than .03).
CONCLUSIONS: These data suggest that intraluminal production of CO2 from the titration of gastric HCO3- by secreted H+ can result in the underestimation of gastric pHi by tonometry. This phenomenon can be eliminated by H2-receptor blockade.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1989762     DOI: 10.1097/00003246-199102000-00025

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  22 in total

1.  Tonometry to estimate intestinal perfusion in newborn piglets.

Authors:  M E Campbell; J E Van Aerde; P Y Cheung; D C Mayes
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-09       Impact factor: 5.747

Review 2.  Monitoring the hepato-splanchnic region in the critically ill patient. Measurement techniques and clinical relevance.

Authors:  A Brinkmann; E Calzia; K Träger; P Radermacher
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

3.  Effect of nasogastric suction and ranitidine on the calculated gastric intramucosal pH.

Authors:  I Parviainen; O Vaisänen; E Ruokonen; J Takala
Journal:  Intensive Care Med       Date:  1996-04       Impact factor: 17.440

Review 4.  Monitoring tissue perfusion.

Authors:  J L Vincent
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

5.  Acute normovolaemic haemodilution does not aggravate gastric mucosal acidosis during cardiac surgery.

Authors:  A Bacher; N Mayer; A M Rajek; W Haider
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

Review 6.  The role of gut mucosal hypoperfusion in the pathogenesis of post-operative organ dysfunction.

Authors:  M G Mythen; A R Webb
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

7.  Intra-operative gut mucosal hypoperfusion is associated with increased post-operative complications and cost.

Authors:  M G Mythen; A R Webb
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

8.  Low intramucosal pH is associated with failure to acidify the gastric lumen in response to pentagastrin.

Authors:  D Higgins; M G Mythen; A R Webb
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

9.  Splanchnic oxygen transport after cardiac surgery: evidence for inadequate tissue perfusion after stabilization of hemodynamics.

Authors:  A Uusaro; E Ruokonen; J Takala
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

10.  Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006.

Authors:  Massimo Antonelli; Mitchell Levy; Peter J D Andrews; Jean Chastre; Leonard D Hudson; Constantine Manthous; G Umberto Meduri; Rui P Moreno; Christian Putensen; Thomas Stewart; Antoni Torres
Journal:  Intensive Care Med       Date:  2007-04       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.